A CLABSI is a blood infection in someone who has a central line, such as a PICC, port or tunnelled line, counted when the line had been in for more than two days. Careful line care, clean hands and a chlorhexidine skin clean lower the risk.
For surveillance, the CDC National Healthcare Safety Network (manual chapter 4, January 2026) defines CLABSI as "a laboratory confirmed bloodstream infection where an eligible BSI organism is identified, and an eligible central line is present on the LCBI DOE or the day before", an eligible central line being one in place for more than two consecutive calendar days after first access in an inpatient location. Its mucosal barrier injury category (MBI-LCBI) is a subset of laboratory-confirmed bloodstream infection with specified organisms in patients who are allogeneic stem cell transplant recipients within the past year with grade III or IV gut graft-versus-host disease or heavy diarrhoea, or who have neutropenia.
The SHEA/IDSA/APIC 2022 update stresses that the surveillance definition differs from the clinical diagnosis of catheter-related bloodstream infection (CRBSI), which depends on laboratory methods, catheter removal and tip culture, and names oncology patients among the vulnerable groups prevention should reach. Its essential practices span insertion, maintenance and surveillance.
Showing the technology this term belongs to: Peripherally inserted central catheters (PICC lines).
Shares Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line) and the tag supportive-care-gaps-2026-11.
Shares Febrile neutropenia and the tag supportive-care-gaps-2026-11.
Shares Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line) and the tag supportive-care-gaps-2026-11.
Shares Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line) and the tag supportive-care-gaps-2026-11.
Shares Catheter lock solutions (heparin, taurolidine and DefenCath), Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line).
Shares Disinfecting caps for needleless connectors (Curos), Peripherally inserted central catheters (PICC lines), Central venous access (port, PICC line).
Shares Disinfecting caps for needleless connectors (Curos), Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line).
Shares Catheter lock solutions (heparin, taurolidine and DefenCath), Peripherally inserted central catheters (PICC lines), Implanted ports for chemotherapy (port-a-cath, power-injectable, apheresis and intraperitoneal ports), Central venous access (port, PICC line).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/